Promoter holding
64.27%
FP
Fluidex Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Fluidex Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gr…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Fluidex Pharmaceuticals Private Limited — 360° Intelligence Report
Generated from MCA filings & public records83/100
Trust Score
Low Risk
Fluidex Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 83/100. Fluidex Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2013, operating in the Travel and Hospitality sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 10 Aug 2026 from the latest processed filings. Fluidex Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
50/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 88/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
05
Director Intelligence
Stability score: 50/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SHUKTHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Nagurao Venkateshwara Rao | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ajay Kumar Sharma | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- SHUKTHA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 90
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
No critical warning flags detected in the available data.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment88/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 8 events22 Oct 2025
Director appointed
Ajay Kumar Sharma (Director)
30 May 2025
Director appointed
SHUKTHA (Director)
Last AGM held
Annual general meeting
22 Feb 2025
Director appointed
Nagurao Venkateshwara Rao (Director)
31 Mar 2024
Latest balance sheet
Filed with ROC
31 Aug 2021
Securities allotted
49000 Equity Shares - 49.00 Lakh raised
01 Dec 2020
Director ceased
SHUKTHA
04 Nov 2013
Incorporated
Registered with Roc Ernakulam
10
Key Observations
Auto-generated from the data aboveNet worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Sightia Management Consultants Private Limited | U74999TG2022PTC158467 | Hyderabad, Telangana, India |
| Ssc Automation Private Limited | U31900GJ2021PTC127164 | Ahmedabad, Gujarat, India |
| Jitnat Infrastructure Private Limited | U45203MH2003PTC139246 | Mumbai, Maharashtra, India |
| Esupplier.In | U72900GJ2011PTC067213 | Vadodara, Gujarat, India |
| Mesmerise Softtech Private Limited | U47411PN2022PTC212872 | Pune, Maharashtra, India |
| Aziwa Infosystems Private Limited | U72200TN2011PTC078964 | Chennai, Tamil Nadu, India |
| Smollan India Csr Foundation | U74999MH2018NPL314558 | Thane, Maharashtra, India |
| Vimal Fire And Emergency Services Limited | U52100MH1997PLC108072 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Fluidex Pharmaceuticals Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Fluidex Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Fluidex Pharmaceuticals Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Fluidex Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Fluidex Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Fluidex Pharmaceuticals Private Limited an active company?
Fluidex Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Fluidex Pharmaceuticals Private Limited financially healthy?
Fluidex Pharmaceuticals Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Fluidex Pharmaceuticals Private Limited?
Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Fluidex Pharmaceuticals Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Fluidex Pharmaceuticals Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Fluidex Pharmaceuticals Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Fluidex Pharmaceuticals Private Limited?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
